biotech
biotech Articles
Vanda Pharma shares dropped early to start out the week after the frim announced that it received a Complete Response Letter from the FDA.
Published:
Last Updated:
Akari Therapeutics shares jumped on Wednesday after the firm announced that the FDA has granted Fast Track designation for its stem cell transplant treatment.
Published:
Last Updated:
Deciphera Pharma shares nearly doubled on Tuesday after the firm announced top-line results from its late-stage trial treating patients with gastrointestinal stromal tumors.
Published:
Last Updated:
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
Last Updated:
Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.
Published:
Last Updated:
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Last Updated:
Amarin shares dropped on Friday after the firm announced that it received notice from the FDA that delays a pending supplemental new drug application.
Published:
Last Updated:
Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas, 10 tied mostly to retailing of apparel and accessories, and six are tied to pharmaceuticals and biotech.
Published:
Last Updated:
DBV Tech shares shot up on Thursday after the company announced the submission of paperwork to the FDA for Viaskin Peanut for the treatment of peanut-allergic children.
Published:
Last Updated:
Rhythm Pharma shares jumped on Wednesday after the company announced positive results from two of its late-stage obesity clinical trials.
Published:
Last Updated:
Insulet shares surged after it reported earnings. The company's Omnipod insulin management system saw stellar growth in sales.
Published:
Last Updated:
Minerva Neurosciences shares jumped on Monday after the company announced positive topline results from its two mid-stage studies in major depressive disorder (MDD) and insomnia. Specifically, these...
Published:
Last Updated:
GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction with Pfizer.
Published:
Last Updated:
Amgen shares rose early Wednesday after it released better than expected second-quarter financial results late on Tuesday.
Published:
Last Updated:
Lexicon Pharma shares were absolutely crushed on Monday after it was announced that Sanofi would be ending its partnership with the firm.
Published:
Last Updated: